A 47 year old patient has been treated for psychotic depression for the last 5 years. The illness began manifesting through the symptoms of depressive thoughts, intrapsychic tension, projectivity, derealisation phenomena and pre-psychotic fears. She was treated with a combination of antidepressives, anxiolitics and hypnotics in ambulatory conditions. The therapy applied did not obtain the effects expected due to which an atypical antipsychotic was administered subsequently - risperidone, a 2 mg dose in the evening. After commencing the antipsychotic treatment, the symptoms started to weaken and a steady remission was obtained. Two years after a regular risperidone administration (in combination with fluoxetine, alprazolam and flurazepam) the patient reported some "bleeding" in October 2006. Hormonal blood tests were performed and high prolactin values were registered (2567.0 mIJ/L),due to which a gradual risperidone retractement was indicated. Medicamentous hyperprolactinaemia is a well known side effect of risperidone. A gradual risperidone retractement lead to a lowered and normal prolactin level within a month.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Use of Long-Acting Injectables for Severe Mental Illness in the Peripartum Period: A Case Report and a Scoping Review.
Cureus
October 2024
Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, USA.
The management of acute mania during pregnancy poses a complex clinical task, necessitating careful consideration of treatment options and demanding a delicate balance between the risks associated with medication use and the adverse impacts of untreated severe mental illness on the fetus. Medication nonadherence stands out as a significant factor contributing to relapse, with rates potentially reaching 40%. The pharmacokinetic profile of long-acting injectable (LAI) risperidone contrasts with that of oral risperidone, characterized by a gradual and consistent release from the depot, mitigating fluctuations between peak and trough concentrations.
View Article and Find Full Text PDFArticle Synopsis
- Delusional parasitosis is a psychotic disorder where individuals believe they are infested with parasites, while shared paranoid disorder (folie à deux) occurs when two closely related people share similar delusions.
- A case study involving a married couple revealed that the husband experienced sensations and beliefs about parasites, leading to the wife also developing similar symptoms, indicating a shared delusion.
- Treatment included medications like sertraline and risperidone, but due to side effects and financial constraints, the husband's condition required adjustments, and separating the couple's sleeping arrangements significantly alleviated the wife's symptoms.
Risperidone-Induced Urinary Incontinence in Schizoaffective Disorder: A Case Report.
Cureus
August 2024
Psychiatry, Al Amal Psychiatric Hospital, Dubai, ARE.
Risperidone is a widely used atypical antipsychotic known for its efficacy in managing various psychiatric conditions. However, it is not without adverse effects, and one such underreported side effect is that of urinary incontinence. This case report highlights the experience of a 59-year-old gentleman with a diagnosis of schizoaffective disorder who, after being admitted due to a relapse of his symptoms, developed urinary incontinence with risperidone.
View Article and Find Full Text PDFRisperidone Pellets, Pycnogenol, and Glucomannan Gummy Formulation for Managing Weight Gain and ADHD in Autistic Children.
Pharmaceutics
August 2024
Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.
Gummy formulations are defined as gradually or slowly released solid oral dosage forms. Risperidone is an atypical antipsychotic medication used to treat schizophrenia and autism-related irritability. This study presents the development of visually appealing, patient-tailored medicated gummies that act as a novel pharmaceutical form of Risperidone for pediatrics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!